Eli Lilly (NYSE:LLY) recently announced its plans to invest $27 billion in four new U.S. manufacturing plants over the next five years, creating thousands of jobs. This move comes at a time when ...

We recently published a list of the 11 Best Pharma Stocks to Buy According to Hedge Funds. In this article, we are going to ...

LLY)) stands against other stocks that Jim Cramer commented discussed recently. On Thursday, Jim Cramer, the host of Mad Money, discussed the recent turbulence in the stock market, pointing to the ...

Eli Lilly (LLY) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.

ELI LILLY AND CO (LLY) is a large-cap growth stock in the Biotechnology & Drugs industry. The rating using this strategy is 88% based on the firm’s underlying fundamentals and the stock’s ...

ELI LILLY AND CO (LLY) is a large-cap growth stock in the Biotechnology & Drugs industry. The rating using this strategy is 88% based on the firm’s underlying fundamentals and the stock’s ...

Noting Eli Lilly and Company (NYSE:LLY) stock gains, a caller asked if they should cash in or hold on. Here’s what Cramer said in reply: “You don’t sell Lilly. Lilly’s got the solution ...

Back in December, I argued why I was ready to upgrade the stock of the embattled weight loss drugs leader Eli Lilly and Company (NYSE:LLY) even as it fell into a bear market after peaking in August.

LLY stock has risen 17% over the last 12 months. Is LLY Stock a Buy? The stock of Eli Lilly has a consensus Strong Buy rating among 17 Wall Street analysts. That rating is based on 16 Buy and one ...

Commenting on the court's decision to reject their motion, Morgan Stanley argued that it would be “an incremental positive” for LLY, and there would be an end to the compounding of Lilly’s ...